- 作者：Fabi谩n A. Z谩rate Moreno ; Luis M. Oms Bernad ; Ra煤l Mato Ruiz ; Cristina Balaguer del Ojo ; Joan Sala Pedr贸s ; Francesc Campillo Alonso
- 关键词：Chyle ; Pancreas ; Pancreatectomy ; Octreotide ; Pancreatitis ; Digestive system fistula
- 刊名：Cirug篓陋a Espa?ola (English Edition)
- 出版年：April, 2013
- 年：2013
- 卷：91
- 期：4
- 页码：237-242
- 全文大小：386 K
Introduction
A chyle fistula is an uncommon complication following abdominal and pancreatic surgery, particularly in the retroperitoneal compartment. It can also appear as a complication of a severe acute pancreatitis. Medical treatment is the initial approach, but resolution is often slow. Somatostatin or octreotide can help in accelerating the resolution of fistulae.Patients and methods
Patients developing a chyle fistula (output >100 ml/24 h, normal amylase levels and triglyceride concentrations above 110 mg/dl) associated with pancreatic disorders were treated with oral intake restriction and parenteral nutrition, followed by subcutaneous octreotide 0.1 mg/8 h.
Results
Four female patients aged 55-80 years, who underwent pancreatic surgery or presented with an acute pancreatitis, were treated. Chyle fistulae ranging from 100 to 2000 ml/24 h were treated with octreotide, being resolved within five to seven days. No recurrence has been found in a 2-4 years follow up.
Conclusions
We have found that chyle fistula medical treatment is often related to a slow resolution, somatostatin or octreotide administration dramatically reduces its duration. Other previously reported studies have also shown that the quick onset of such treatment can accelerate the whole process, leading to a shorter recovery and lower hospital costs.